5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 180.44▼ | 179.91▼ |
MA10 | N/A | N/A | N/A | 180.30▼ | 174.35▲ |
MA20 | N/A | N/A | N/A | 177.68▼ | 169.37▲ |
MA50 | N/A | N/A | N/A | 172.85▲ | 182.67▼ |
MA100 | N/A | N/A | N/A | 170.93▲ | 177.23▲ |
MA200 | N/A | N/A | N/A | 182.99▼ | 148.64▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.227▼ | 2.630▲ |
RSI | N/A | N/A | N/A | 50.308▲ | 50.564▲ |
STOCH | N/A | N/A | N/A | 57.533 | 76.199 |
WILL %R | N/A | N/A | N/A | -46.285 | -24.713▲ |
CCI | N/A | N/A | N/A | -2.644 | 64.709 |
Monday, June 30, 2025 02:00 AM
Highlights of a Pivotal Year for IGC Pharma: Positive Interim Data Reinforces IGC-AD1's Potential: April 2, 2024 - IGC Pharma released positive interim data from its ongoing Phase 2 CALMA trial ...
|
Sunday, March 30, 2025 05:00 PM
POTOMAC, MARYLAND/ ACCESS Newswire/ June 30, 2025/ IGC Pharma, Inc., a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's and metabolic disorders ...
|
Tuesday, January 28, 2025 10:08 AM
IGC Pharma, Inc. (IGC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
04/07/25 | 177.50 | 177.50 | 177.50 | 177.50 | 30,438 |
03/07/25 | 178.945 | 179.00 | 174.00 | 177.50 | 396,565 |
27/06/25 | 187.84 | 187.84 | 187.84 | 187.84 | 233,854 |
25/06/25 | 170.9001 | 174.50 | 170.00 | 173.50 | 276,929 |
24/06/25 | 185.85 | 185.85 | 185.85 | 185.85 | 71,514 |
23/06/25 | 169.84 | 174.00 | 169.50 | 171.00 | 77,846 |
20/06/25 | 183.69 | 183.69 | 183.69 | 183.69 | 51,809 |
19/06/25 | 183.33 | 183.33 | 183.33 | 183.33 | 71,219 |
18/06/25 | 185.76 | 185.76 | 185.76 | 185.76 | 109,437 |
11/06/25 | 178.00 | 180.00 | 177.00 | 177.00 | 309,672 |
|
|
||||
|
|
||||
|
|